5014 G
Pill imprint 5014 G has been identified as Hydrochlorothiazide and spironolactone 25 mg / 25 mg.
Hydrochlorothiazide/spironolactone is used in the treatment of edema; nephrotic syndrome; high blood pressure; ascites; heart failure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy.
Hydrochlorothiazide/spironolactone 25 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydrochlorothiazide and spironolactone Images
- Imprint:
-
5014
G - Strength:
- 25 mg / 25 mg
- Color:
- Beige
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium sulfate
corn starch
flavor
hydroxypropyl cellulose
hypromellose
ferric oxide
magnesium stearate
polyethylene glycol
povidone
titanium dioxide
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Greenstone Limited
- National Drug Code (NDC):
- 59762-5014
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-0502 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Hydrochlorothiazide and Spironolactone resources
- Hydrochlorothiazide/Spironolactone (Wolters Kluwer)
- Spironolactone/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and spironolactone (Cerner Multum)
- spironolactone and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Spironolactone and Hydrochlorothiazide (FDA)
- Spironolactone/Hydrochlorothiazide (Wolters Kluwer)
Search Again
